Two faculty members from Weill Cornell Medicine and one from the College of Veterinary Medicine have been elected to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.
Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.
Researchers have demonstrated the use of artificial-intelligence-selected natural images and AI-generated synthetic images as neuroscientific tools for probing the visual processing areas of the brain.
With a bit of funding, high school students not only helped their neighbors but also offered researchers insights into how young people think about their capacity to make a difference.
Weill Cornell Medicine is dramatically expanding its campus and research footprint in New York City by securing five floors of 1334 York Ave., the current home of Sotheby's auction house.
A multi-institution team led by a Weill Cornell Medicine scientist has been approved for $30 million in funding from the Patient-Centered Outcomes Research Institute to study heart procedure outcomes in underrepresented groups.
Using low-frequency radio waves to send blood pressure data, a group of students has provided a proof of concept that could enable in-home health care for people without cellular or broadband access.
Researchers at Weill Cornell Medicine have found that radiation therapy combined with two types of immunotherapy can control tumors in preclinical models of triple-negative breast cancer, which is typically resistant to immunotherapy alone.
A novel combination of artificial intelligence and production techniques could change the future of nanomedicine, according to Cornell researchers using a new $3 million grant from the National Science Foundation to revolutionize how polymer nanoparticles are manufactured.